342 related articles for article (PubMed ID: 18724249)
21. Prognostic value of immunohistochemical classification of diffuse large B-cell lymphoma into germinal center B-cell and non-germinal center B-cell subtypes.
Saad AA; Awed NM; Abdel-Hafeez ZM; Kamal GM; Elsallaly HM; Alloub AI
Saudi Med J; 2010 Feb; 31(2):135-41. PubMed ID: 20174727
[TBL] [Abstract][Full Text] [Related]
22. FOXP1 expression and its clinicopathologic significance in nodal and extranodal diffuse large B-cell lymphoma.
Yu B; Zhou X; Li B; Xiao X; Yan S; Shi D
Ann Hematol; 2011 Jun; 90(6):701-8. PubMed ID: 21120478
[TBL] [Abstract][Full Text] [Related]
23. Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma.
Cha EJ; Noh SJ; Kwon KS; Kim CY; Park BH; Park HS; Lee H; Chung MJ; Kang MJ; Lee DG; Moon WS; Jang KY
Clin Cancer Res; 2009 Jul; 15(13):4453-9. PubMed ID: 19509139
[TBL] [Abstract][Full Text] [Related]
24. BCL2 gene aberration as an IPI-independent marker for poor outcome in non-germinal-centre diffuse large B cell lymphoma.
Obermann EC; Csato M; Dirnhofer S; Tzankov A
J Clin Pathol; 2009 Oct; 62(10):903-7. PubMed ID: 19783718
[TBL] [Abstract][Full Text] [Related]
25. LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab.
Natkunam Y; Farinha P; Hsi ED; Hans CP; Tibshirani R; Sehn LH; Connors JM; Gratzinger D; Rosado M; Zhao S; Pohlman B; Wongchaowart N; Bast M; Avigdor A; Schiby G; Nagler A; Byrne GE; Levy R; Gascoyne RD; Lossos IS
J Clin Oncol; 2008 Jan; 26(3):447-54. PubMed ID: 18086797
[TBL] [Abstract][Full Text] [Related]
26. Perforation predicts poor prognosis in patients with primary intestinal diffuse large B-cell lymphoma.
Chuang SS; Ye H; Yang SF; Huang WT; Chen HK; Hsieh PP; Hwang WS; Chang KY; Lu CL; Du MQ
Histopathology; 2008 Oct; 53(4):432-40. PubMed ID: 18983608
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study.
Linderoth J; Jerkeman M; Cavallin-Ståhl E; Kvaløy S; Torlakovic E;
Clin Cancer Res; 2003 Feb; 9(2):722-8. PubMed ID: 12576441
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of the bcl6 and CD10 proteins is associated with increased apoptosis and proliferation in diffuse large B-cell lymphomas.
Bai M; Agnantis NJ; Skyrlas A; Tsanou E; Kamina S; Galani V; Kanavaros P
Mod Pathol; 2003 May; 16(5):471-80. PubMed ID: 12748254
[TBL] [Abstract][Full Text] [Related]
29. Expression of LMO2 is associated with t(14;18)/IGH-BCL2 fusion but not BCL6 translocations in diffuse large B-cell lymphoma.
Durnick DK; Law ME; Maurer MJ; Natkunam Y; Levy R; Lossos IS; Kurtin PJ; McPhail ED
Am J Clin Pathol; 2010 Aug; 134(2):278-81. PubMed ID: 20660332
[TBL] [Abstract][Full Text] [Related]
30. Primary diffuse large B-cell lymphomas of the bone: prognostic relevance of protein expression and clinical factors.
Adams H; Tzankov A; d'Hondt S; Jundt G; Dirnhofer S; Went P
Hum Pathol; 2008 Sep; 39(9):1323-30. PubMed ID: 18614198
[TBL] [Abstract][Full Text] [Related]
31. Cluster analysis of apoptosis-associated bcl2 family proteins in diffuse large B-cell lymphomas. Relations with the apoptotic index, the proliferation profile and the B-cell differentiation immunophenotypes.
Bai M; Skyrlas A; Agnantis NJ; Kamina S; Kitsoulis P; Kanavaros P
Anticancer Res; 2004; 24(5A):3081-8. PubMed ID: 15517919
[TBL] [Abstract][Full Text] [Related]
32. Primary testicular diffuse large B-cell lymphoma shows an activated B-cell-like phenotype.
Li D; Xie P; Mi C
Pathol Res Pract; 2010 Sep; 206(9):611-5. PubMed ID: 20627604
[TBL] [Abstract][Full Text] [Related]
33. FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3p14.1.
Hoeller S; Schneider A; Haralambieva E; Dirnhofer S; Tzankov A
Histopathology; 2010 Jul; 57(1):73-80. PubMed ID: 20579129
[TBL] [Abstract][Full Text] [Related]
34. Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma.
Linderoth J; Ehinger M; Akerman M; Cavallin-Ståhl E; Enblad G; Erlanson M; Jerkeman M
Eur J Haematol; 2007 Aug; 79(2):146-9. PubMed ID: 17635238
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of inflammatory cytokines at diagnosis correlate to the bcl-6 and CD10 defined germinal centre (GC) phenotype and bcl-2 expression in patients with diffuse large B-cell lymphoma.
Pedersen LM; Jürgensen GW; Johnsen HE
Br J Haematol; 2005 Mar; 128(6):813-9. PubMed ID: 15755285
[TBL] [Abstract][Full Text] [Related]
36. The impact of P53 and P21(waf1) expression on the survival of patients with the germinal center phenotype of diffuse large B-cell lymphoma.
Visco C; Canal F; Parolini C; Andreoli A; Ambrosetti A; Krampera M; Lestani M; Pizzolo G; Chilosi M
Haematologica; 2006 May; 91(5):687-90. PubMed ID: 16670073
[TBL] [Abstract][Full Text] [Related]
37. Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma.
Dierlamm J; Murga Penas EM; Bentink S; Wessendorf S; Berger H; Hummel M; Klapper W; Lenze D; Rosenwald A; Haralambieva E; Ott G; Cogliatti SB; Möller P; Schwaenen C; Stein H; Löffler M; Spang R; Trümper L; Siebert R;
Haematologica; 2008 May; 93(5):688-96. PubMed ID: 18367485
[TBL] [Abstract][Full Text] [Related]
38. CD10 and Bcl-2 expression combined with the International Prognostic Index can identify subgroups of patients with diffuse large-cell lymphoma with very good or very poor prognoses.
Biasoli I; Morais JC; Scheliga A; Milito CB; Romano S; Land M; Pulcheri W; Spector N
Histopathology; 2005 Mar; 46(3):328-33. PubMed ID: 15720419
[TBL] [Abstract][Full Text] [Related]
39. Expression of TNF-receptor associated factor 2 correlates with poor progression-free survival time in ABC-like primary nodal diffuse large B-cell lymphomas.
van Galen JC; Muris JJ; Giroth CP; Vos W; Ossenkoppele GJ; Meijer CJ; Oudejans JJ
Histopathology; 2008 Apr; 52(5):578-84. PubMed ID: 18312353
[TBL] [Abstract][Full Text] [Related]
40. [Expression of microRNA-223 and its clinicopathologic correlation in diffuse large B-cell lymphoma].
Yao XX; Wang JF; Wang YH; Gao N
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):366-70. PubMed ID: 22932402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]